Millions Logo
home>US Stocks>Prelude Therapeutics
PRLD
Prelude TherapeuticsHealthcare
$3.53+$2.18 (+161.11%)in 1 year
As on 13 Nov 2026 at 02:29NASDAQ
52 Week Low: $1.2152 Week High: $6.83

Prelude Therapeutics Share Price Today

Prelude Therapeutics opened lower at $3.73, compared with its previous close of $3.78. In the last trading session, the stock traded between $3.50 and $3.73. It showed a downward intraday trend.

Return calculator

Time Period

An investment of $100 made 5 years ago in Prelude Therapeutics is now worth

$ 21.03

Resulting in a loss of

$ 78.97 (78.97%)

Invest with $1

Note: Past profits do not guarantee future returns.

Analyst Overview

Buy

Rating from 2 Analysts

Buy
100%
Hold
0%
Sell
0%

Markets Today

Today's Change

$-0.26 (-6.75%)

Day High

$3.73

Day Low

$3.50

Day Open

$3.73

Prev Close

$3.78

Volume

1,82,986

1W Return

-13.79%

1M Return

-5.87%

3M Return

-33.57%

6M Return

-26.56%

1Y Return

161.11%

Fundamentals

Market Cap ($ Mn)

229

PE Ratio

-

PB Ratio

3.26

PEG Ratio

-

ROE

-113.67%

ROCE

-93.82%

EPS (TTM)

$-0.17

Investment Returns

1 Week

-13.79%

1 Month

-5.87%

3 Months

-33.57%

6 Months

-26.56%

9 Months

68.66%

Financials

Quarterly
All values in $ Mn
4.0

Dec 24
0.0

Mar 25
0.0

Jun 25
6.5

Sep 25
5.6

Dec 25
5.7

Jun 26

Updates

13Oct

Prelude Therapeutics signs supply deal with Eli Lilly for cancer trial

Prelude Therapeutics enters clinical trial collaboration with Eli Lilly. Agreement supplies abemaciclib and imlunestrant for Phase 1 trial of PRT13722. FDA cleared IND application; enrolment starts Q4 2026. Preclinical data shows improved safety profile versus dual KAT6A/B inhibitors.

1mo ago
10Sep

Prelude Therapeutics secures FDA clearance for PRT13722 breast cancer study

FDA clears IND for PRT13722, an oral KAT6A selective degrader. Phase 1 trial targets HR+/HER2- breast cancer patients. Patient enrollment expected to begin in Q4 2026. Strategy aims to improve safety over dual KAT6A/B inhibitors.

2mo ago

Similar Stocks

StockLTPChange %Market CapPE
$547.03-0.16%$1,38,692.89M31.55
$61.05+0.38%$1,31,510.31M14.39
$248.69-0.85%$1,00,625.20M-
$959.41+4.73%$97,505.80M19.64
$977.58+0.62%$61,476.10M38.99
$419.98-0.95%$46,108.31M65.60
$180.70-6.40%$39,083.96M-
$53.87-0.37%$33,618.11M26.24
$70.01+0.81%$31,173.07M32.37
$41.85+1.60%$30,322.88M-
$120.75+1.05%$26,490.14M-
$122.27+1.64%$24,922.54M15.85